2024 Q1 Form 10-Q Financial Statement

#000005697824000034 Filed on February 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $172.1M $171.2M
YoY Change -40.21%
Cost Of Revenue $155.6M $91.29M
YoY Change -40.57%
Gross Profit $16.47M $79.90M
YoY Change -39.79%
Gross Profit Margin 9.57% 46.67%
Selling, General & Admin $39.45M $41.39M
YoY Change 32.35%
% of Gross Profit 239.51% 51.81%
Research & Development $37.70M $36.81M
YoY Change 13.77%
% of Gross Profit 228.91% 46.07%
Depreciation & Amortization $5.642M $7.985M
YoY Change 481.15%
% of Gross Profit 34.25% 9.99%
Operating Expenses $121.6M $78.20M
YoY Change 20.3%
Operating Profit -$105.2M $1.693M
YoY Change -97.5%
Interest Expense $18.00K $22.00K
YoY Change -99.45%
% of Operating Profit 1.3%
Other Income/Expense, Net
YoY Change
Pretax Income -$96.33M $11.57M
YoY Change -83.83%
Income Tax $6.355M $2.277M
% Of Pretax Income 19.68%
Net Earnings -$102.7M $9.293M
YoY Change -85.68%
Net Earnings / Revenue -59.67% 5.43%
Basic Earnings Per Share -$1.83 $0.16
Diluted Earnings Per Share -$1.83 $0.16
COMMON SHARES
Basic Shares Outstanding 56.34M shares 56.72M shares
Diluted Shares Outstanding 56.15M shares 57.02M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $634.7M $709.7M
YoY Change -8.49%
Cash & Equivalents $359.7M $424.7M
Short-Term Investments $375.0M $445.0M
Other Short-Term Assets $40.31M $47.04M
YoY Change -24.38%
Inventory $180.5M $236.6M
Prepaid Expenses
Receivables $194.8M $184.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.050B $1.178B
YoY Change -11.59%
LONG-TERM ASSETS
Property, Plant & Equipment $65.00M $107.3M
YoY Change 32.59%
Goodwill $89.08M $89.52M
YoY Change 31.46%
Intangibles $27.14M $28.92M
YoY Change -9.46%
Long-Term Investments $2.254M $2.042M
YoY Change -62.16%
Other Assets $10.06M $3.390M
YoY Change 17.95%
Total Long-Term Assets $248.3M $309.1M
YoY Change 20.47%
TOTAL ASSETS
Total Short-Term Assets $1.050B $1.178B
Total Long-Term Assets $248.3M $309.1M
Total Assets $1.299B $1.487B
YoY Change -6.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.49M $58.68M
YoY Change -12.82%
Accrued Expenses $43.45M $44.04M
YoY Change -25.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $165.7M $181.3M
YoY Change -27.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.46M $12.15M
YoY Change 4.1%
Total Long-Term Liabilities $13.46M $12.15M
YoY Change 4.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $165.7M $181.3M
Total Long-Term Liabilities $13.46M $12.15M
Total Liabilities $286.5M $325.5M
YoY Change -17.38%
SHAREHOLDERS EQUITY
Retained Earnings $1.240B $1.354B
YoY Change 0.9%
Common Stock $584.6M $578.5M
YoY Change 2.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $794.2M $756.9M
YoY Change 12.01%
Treasury Stock Shares
Shareholders Equity $1.012B $1.161B
YoY Change
Total Liabilities & Shareholders Equity $1.299B $1.487B
YoY Change -6.41%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$102.7M $9.293M
YoY Change -85.68%
Depreciation, Depletion And Amortization $5.642M $7.985M
YoY Change 481.15%
Cash From Operating Activities -$20.15M -$7.331M
YoY Change -106.29%
INVESTING ACTIVITIES
Capital Expenditures $6.571M $4.426M
YoY Change -135.11%
Acquisitions
YoY Change
Other Investing Activities $10.00M -$56.12M
YoY Change -198.31%
Cash From Investing Activities $3.429M -$60.54M
YoY Change -189.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -47.67M -$38.12M
YoY Change -45.76%
NET CHANGE
Cash From Operating Activities -20.15M -$7.331M
Cash From Investing Activities 3.429M -$60.54M
Cash From Financing Activities -47.67M -$38.12M
Net Change In Cash -64.39M -$104.7M
YoY Change -192.09%
FREE CASH FLOW
Cash From Operating Activities -$20.15M -$7.331M
Capital Expenditures $6.571M $4.426M
Free Cash Flow -$26.72M -$11.76M
YoY Change -109.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91293000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87527000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
79896000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
88706000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41393000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42376000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36810000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34508000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
78203000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
76884000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1693000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
11822000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
9899000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
6559000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
22000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
34000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11570000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18347000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2277000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3758000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56650000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57051000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57023000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57729000 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6280000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
14319000 usd
CY2023Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
67000 usd
CY2022Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
47000 usd
CY2023Q4 klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
6213000 usd
CY2022Q4 klic Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent
ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent
14272000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1255000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
3093000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-215000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-280000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1470000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3373000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7683000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17645000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16976000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32234000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1174561000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
315000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26840000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7542000 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11303000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7683000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16976000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1161251000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1194650000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
237000 usd
CY2022Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
45382000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6284000 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10794000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17645000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32234000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1177229000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7985000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5613000 usd
CY2023Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
7857000 usd
CY2022Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
6521000 usd
CY2023Q4 klic Increase Decrease Due To Inventory Valuation
IncreaseDecreaseDueToInventoryValuation
2789000 usd
CY2022Q4 klic Increase Decrease Due To Inventory Valuation
IncreaseDecreaseDueToInventoryValuation
809000 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-678000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2740000 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-43000 usd
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
256000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
211000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2565000 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3588000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
25619000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-108754000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
22083000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
27229000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7547000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-252000 usd
CY2023Q4 klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-819000 usd
CY2022Q4 klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-32763000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2396000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5745000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1604000 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2233000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7331000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
85116000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4426000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13878000 usd
CY2023Q4 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
1115000 usd
CY2022Q4 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
36000 usd
CY2023Q4 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
215000000 usd
CY2022Q4 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
85000000 usd
CY2023Q4 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
160000000 usd
CY2022Q4 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
60000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60541000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38914000 usd
CY2023Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
173000 usd
CY2022Q4 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
159000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27241000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46328000 usd
CY2023Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
10710000 usd
CY2022Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
9743000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38124000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56230000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1254000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5104000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-104742000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4924000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
529402000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
555537000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424660000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550613000 usd
CY2023Q4 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
893000 usd
CY2022Q4 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
1588000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
22000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
34000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
264000 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4702000 usd
CY2023Q4 us-gaap Basis Of Accounting
BasisOfAccounting
1. BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Annual Report”) filed with the Securities and Exchange Commission on November 16, 2023, which includes the Consolidated Balance Sheets as of September 30, 2023 and October 1, 2022, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended September 30, 2023. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2024 quarters end on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2023 quarters ended on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of December 30, 2023. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended December 30, 2023, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2023 Annual Report. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revision of Segment-Related Disclosures within the Previously Issued Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal year 2023, in response to comment letters from the staff of the Securities and Exchange Commission (the "SEC"), the Company reconsidered the guidance under ASC 280, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in our Annual Report on Form 10-K for the year ended October 1, 2022, originally filed with the SEC on November 17, 2022 (the "Original Form 10-K"). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures in the notes to its consolidated financial statements and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the changes to the Company’s operating and reportable segments, the Company has revised, in this Quarterly Report on Form 10-Q, the segment-related disclosures in Note 14: Segment Information, to update the prior period presentation. The effect of this revision has been reflected in all footnotes impacted by this revision. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Improvements </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, the Financial Accounting Standards Board (the "FASB") issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This ASU aligns the requirements in the FASB Accounting Standards Codification with the SEC’s regulations. The amendments in the ASU are expected to clarify or improve disclosure and presentation requirements of a variety of Codification Topics. They will also allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the requirements, and align the requirements in the Codification with the SEC’s regulations. This ASU will become effective for each amendment on the date on which the SEC removes the related disclosure from its regulations. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective for any entity. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 280): Improvements to Reportable Segment Disclosure, which aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments in the ASU enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity's overall performance and assess potential future cash flows. This ASU will be effective for the Company's fiscal year 2025, and interim periods within the fiscal years beginning after the Company’s fiscal year 2026. Early adoption is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span> (Topic 740): Improvement to Income Tax Disclosures. The amendments in this update are intended to enhance the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. This ASU will be effective for the Company's fiscal year 2026. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
CY2023Q4 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div>Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2024 quarters end on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2023 quarters ended on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023.
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div>In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of December 30, 2023. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended December 30, 2023, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods.
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
119077000 usd
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
114827000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
85499000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
74555000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
55463000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
49207000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
260039000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
238589000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
23481000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
21285000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
236558000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
217304000 usd
CY2023Q4 us-gaap Land
Land
2182000 usd
CY2023Q3 us-gaap Land
Land
2182000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23213000 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23105000 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
83586000 usd
CY2023Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
82927000 usd
CY2023Q4 klic Equipment And Software Gross
EquipmentAndSoftwareGross
38267000 usd
CY2023Q3 klic Equipment And Software Gross
EquipmentAndSoftwareGross
37483000 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
98773000 usd
CY2023Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
95692000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11345000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11099000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257366000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
252488000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
150093000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
142437000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
107273000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
110051000 usd
CY2023Q4 srt Payables To Customers
PayablesToCustomers
36287000 usd
CY2023Q3 srt Payables To Customers
PayablesToCustomers
35701000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23060000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33096000 usd
CY2023Q4 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
11303000 usd
CY2023Q3 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
10710000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
4270000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
4091000 usd
CY2023Q4 klic Accrued Leasehold Renovations
AccruedLeaseholdRenovations
10013000 usd
CY2023Q3 klic Accrued Leasehold Renovations
AccruedLeaseholdRenovations
11005000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6260000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8402000 usd
CY2023Q4 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
91193000 usd
CY2023Q3 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
103005000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
88673000 usd
CY2023Q4 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
843000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
89516000 usd
CY2023Q3 klic Goodwill Cumulative Impairment
GoodwillCumulativeImpairment
45000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
133631000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
104715000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28916000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
130929000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
101572000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29357000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3916000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5153000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5153000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4878000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4438000 usd
CY2023Q4 klic Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
5378000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28916000 usd
CY2023Q4 us-gaap Cash
Cash
39229000 usd
CY2023Q4 klic Cash Unrealized Gains
CashUnrealizedGains
0 usd
CY2023Q4 klic Cash Unrealized Losses
CashUnrealizedLosses
0 usd
CY2023Q4 klic Cash Estimated Fair Value
CashEstimatedFairValue
39229000 usd
CY2023Q4 klic Cashand Cash Equivalents Amortized Cost
CashandCashEquivalentsAmortizedCost
424658000 usd
CY2023Q4 klic Cashand Cash Equivalents Gross Unrealized Gain
CashandCashEquivalentsGrossUnrealizedGain
2000 usd
CY2023Q4 klic Cashand Cash Equivalents Gross Unrealized Loss
CashandCashEquivalentsGrossUnrealizedLoss
0 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
424660000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
285000000 usd
CY2023Q4 klic Availableforsale Securities Shortterm Investments Gross Unrealized Gain
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q4 klic Availableforsale Securities Shortterm Investments Gross Unrealized Loss
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss
0 usd
CY2023Q4 klic Availableforsale Securities Shortterm Investments Fair Value Disclosure
AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure
285000000 usd
CY2023Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments
709658000 usd
CY2023Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain
2000 usd
CY2023Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss
0 usd
CY2023Q4 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure
709660000 usd
CY2023Q3 us-gaap Cash
Cash
37292000 usd
CY2023Q3 klic Cash Unrealized Gains
CashUnrealizedGains
0 usd
CY2023Q3 klic Cash Unrealized Losses
CashUnrealizedLosses
0 usd
CY2023Q3 klic Cash Estimated Fair Value
CashEstimatedFairValue
37292000 usd
CY2023Q3 klic Cashand Cash Equivalents Amortized Cost
CashandCashEquivalentsAmortizedCost
529412000 usd
CY2023Q3 klic Cashand Cash Equivalents Gross Unrealized Gain
CashandCashEquivalentsGrossUnrealizedGain
0 usd
CY2023Q3 klic Cashand Cash Equivalents Gross Unrealized Loss
CashandCashEquivalentsGrossUnrealizedLoss
10000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
529402000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
230000000 usd
CY2023Q3 klic Availableforsale Securities Shortterm Investments Gross Unrealized Gain
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q3 klic Availableforsale Securities Shortterm Investments Gross Unrealized Loss
AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss
0 usd
CY2023Q3 klic Availableforsale Securities Shortterm Investments Fair Value Disclosure
AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure
230000000 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments
759412000 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss
10000 usd
CY2023Q3 klic Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure
759402000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2042000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
716000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2200000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
100000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
42736000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
747000 usd
CY2023Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
54590000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
723000 usd
CY2023Q4 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
48417000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6697000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41720000 usd
CY2023Q4 klic Leases Numberof Options To Extend
LeasesNumberofOptionsToExtend
4 extend_options
CY2023Q4 us-gaap Lease Cost
LeaseCost
2857000 usd
CY2022Q4 us-gaap Lease Cost
LeaseCost
2590000 usd
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
2422000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
2284000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7346000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9632000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8959000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7052000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6590000 usd
CY2023Q4 klic Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
23110000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
62689000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14272000 usd
CY2017Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000 usd
CY2022Q1 klic Stock Repurchase Program Authorized Amount Additional Amount
StockRepurchaseProgramAuthorizedAmountAdditionalAmount
400000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
800000000 usd
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2023Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
10700000 usd
CY2023Q4 klic Relative Total Shareholder Return Average Stock Price Calculation Period
RelativeTotalShareholderReturnAverageStockPriceCalculationPeriod
P90D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
786000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
792000 shares
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7857000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6521000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7857000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6521000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10181000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
26317000 usd
CY2023Q4 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2022Q4 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2670000 usd
CY2023Q4 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-10181000 usd
CY2022Q4 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
0 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
28987000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4797000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3160000 usd
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-8543000 usd
CY2022Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-7270000 usd
CY2023Q4 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
12325000 usd
CY2022Q4 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
11891000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8579000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7781000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
9293000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14589000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56650000 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56650000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57051000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57051000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
373000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
678000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57023000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57729000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q4 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
0
CY2022Q4 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.01
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000 shares
CY2022Q4 us-gaap Depreciation
Depreciation
4219000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1347000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2277000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3758000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q4 us-gaap Revenues
Revenues
171189000 usd
CY2022Q4 us-gaap Revenues
Revenues
176233000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1693000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
11822000 usd
CY2023Q4 us-gaap Revenues
Revenues
171189000 usd
CY2022Q4 us-gaap Revenues
Revenues
176233000 usd
CY2023Q4 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
3533000 usd
CY2022Q4 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
15651000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
6638000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1394000 usd
CY2023Q4 klic Period Of Warranty For Manufacturing Defects
PeriodOfWarrantyForManufacturingDefects
P1Y
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10457000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13443000 usd
CY2023Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2936000 usd
CY2022Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2100000 usd
CY2023Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3226000 usd
CY2022Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4122000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10167000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
11421000 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due
InventoryPurchaseObligationFutureMinimumPaymentsDue
167469000 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due Current
InventoryPurchaseObligationFutureMinimumPaymentsDueCurrent
97313000 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due In Two Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInTwoYears
70156000 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due In Three Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInThreeYears
0 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due In Four Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFourYears
0 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due In Five Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFiveYears
0 usd
CY2023Q4 klic Inventory Purchase Obligation Future Minimum Payments Due Thereafter
InventoryPurchaseObligationFutureMinimumPaymentsDueThereafter
0 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
klic-20231230_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000056978-24-000034-index-headers.html Edgar Link pending
0000056978-24-000034-index.html Edgar Link pending
0000056978-24-000034.txt Edgar Link pending
0000056978-24-000034-xbrl.zip Edgar Link pending
a10qq12024ex311.htm Edgar Link pending
a10qq12024ex312.htm Edgar Link pending
a10qq12024ex321.htm Edgar Link pending
a10qq12024ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
klic-20231230.htm Edgar Link pending
klic-20231230.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
klic-20231230_cal.xml Edgar Link unprocessable
klic-20231230_lab.xml Edgar Link unprocessable
klic-20231230_pre.xml Edgar Link unprocessable
klic-20231230_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending